The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Boston Scientific Corp

NYSE: BSX
Last

(U.S.) $28.72

Today's change+0.03 +0.10%
Updated September 20 9:35 AM EDT. Delayed by at least 15 minutes.
 

Boston Scientific Corp

NYSE: BSX
Last

(U.S.) $28.72

Today's change+0.03 +0.10%
Updated September 20 9:35 AM EDT. Delayed by at least 15 minutes.

Boston Scientific Corp up (U.S.)$0.03

Boston Scientific Corp is up today by (U.S.)$0.03 or 0.10% to (U.S.)$28.72. Shares have lost 1.24% over the last five days, but sit 2.31% below their 52-week high. This security has outperformed the S&P 500 by 6.04% during the last year.

Key company metrics

  • Open(U.S.) $28.68
  • Previous close(U.S.) $28.69
  • High(U.S.) $28.79
  • Low(U.S.) $28.68
  • Bid / Ask(U.S.) $28.71 / (U.S.) $28.72
  • YTD % change+32.78%
  • Volume66,097
  • Average volume (10-day)5,397,316
  • Average volume (1-month)4,793,399
  • Average volume (3-month)5,880,702
  • 52-week range(U.S.) $19.67 to (U.S.) $29.40
  • Beta1.09
  • Trailing P/E50.32×
  • P/E 1 year forward22.84×
  • Forward PEG1.98×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.57
Updated September 20 9:35 AM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue2,2572,1602,1912,105
Total other revenue--------
Total revenue2,2572,1602,1912,105
Gross profit1,6371,5221,5861,519
Total cost of revenue620638605586
Total operating expense2,0321,7962,0511,757
Selling / general / administrative812791828768
Research & development244235256232
Depreciation / amortization142143137136
Interest expense (income), net operating--------
Unusual expense (income)2212219928
Other operating expenses, total-7-33267
Operating income225364140348
Interest income (expense), net non-operating-58-57-58-58
Gain (loss) on sale of assets--------
Other--------
Income before tax9130589257
Income after tax146290124228
Income tax, total-5515-3529
Net income146290124228
Total adjustments to net income--------
Net income before extra. items146290124228
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items146290124228
Inc. avail. to common incl. extra. items146290124228
Diluted net income146290124228
Dilution adjustment--------
Diluted weighted average shares1,3911,3901,3841,361
Diluted EPS excluding extraordinary itemsvalue per share0.100.210.090.17
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share0.210.220.180.19